Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of β-catenin
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of β-catenin
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-27
DOI
10.1038/s41401-022-00908-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Review of Drug Therapy in Vestibular Schwannoma
- (2021) Jianfei Long et al. Drug Design Development and Therapy
- Celastrol Attenuates Lipid Accumulation and Stemness of Clear Cell Renal Cell Carcinoma via CAV-1/LOX-1 Pathway
- (2021) Chan-Juan Zhang et al. Frontiers in Pharmacology
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Merlin regulates signaling events at the nexus of development and cancer
- (2020) Mateus Mota et al. Cell Communication and Signaling
- Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application
- (2020) Jinfeng Shi et al. Frontiers in Pharmacology
- Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
- (2019) Jerry Harb et al. Current Oncology Reports
- Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells
- (2019) Xihong Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway
- (2019) Zhe Cha et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CYP450s-Activity Relations of Celastrol to Interact with Triptolide Reveal the Reasons of Hepatotoxicity of Tripterygium wilfordii
- (2019) Chunhuan Jin et al. MOLECULES
- EANO Guideline on the Diagnosis and Treatment of Vestibular Schwannoma
- (2019) Roland Goldbrunner et al. NEURO-ONCOLOGY
- Integrated metabolomics and network toxicology to reveal molecular mechanism of celastrol induced cardiotoxicity
- (2019) Chuanxin Liu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles
- (2018) Yue Zhao et al. DRUG DELIVERY
- Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma
- (2018) Muthu K. Shanmugam et al. Frontiers in Pharmacology
- Dietary Natural Products for Prevention and Treatment of Breast Cancer
- (2017) Ya Li et al. Nutrients
- Evaluation of connectivity map-discovered celastrol as a radiosensitizing agent in a murine lung carcinoma model: Feasibility study of diffusion-weighted magnetic resonance imaging
- (2017) Hong Young Jun et al. PLoS One
- Merlin inhibits Wnt/β-catenin signaling by blocking LRP6 phosphorylation
- (2016) M Kim et al. CELL DEATH AND DIFFERENTIATION
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/ -Catenin Signaling
- (2015) M. Quan et al. CANCER RESEARCH
- Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment
- (2015) Vanna Sanna et al. International Journal of Nanomedicine
- Role of Merlin/NF2 inactivation in tumor biology
- (2015) A M Petrilli et al. ONCOGENE
- Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy
- (2015) Hyun-Woo Lee et al. BMB Reports
- Merlin-Deficient Human Tumors Show Loss of Contact Inhibition and Activation of Wnt/β-Catenin Signaling Linked to the PDGFR/Src and Rac/PAK Pathways
- (2015) Lu Zhou et al. NEOPLASIA
- Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9
- (2014) CHUNLIU MI et al. ONCOLOGY REPORTS
- Celastrol Induces Apoptosis of Gastric Cancer Cells by miR-21 Inhibiting PI3K/Akt-NF-κB Signaling Pathway
- (2014) Min Sha et al. PHARMACOLOGY
- Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity
- (2013) Min Sun et al. FITOTERAPIA
- Development of B Cells and Erythrocytes Is Specifically Impaired by the Drug Celastrol in Mice
- (2012) Sophie Kusy et al. PLoS One
- Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers
- (2011) Srikumar M. Raja et al. CANCER BIOLOGY & THERAPY
- Celastrol Inhibits Breast Cancer Cell Invasion via Suppression of NF-ĸB-mediated Matrix Metalloproteinase-9 Expression
- (2011) Yoonseo Kim et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Formulation and Evaluation of Celastrol-Loaded Liposomes
- (2011) Jie Song et al. MOLECULES
- NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation
- (2010) E E Bosco et al. ONCOGENE
- Wnt/β-catenin signaling in hepatic organogenesis
- (2010) Kari Nejak-Bowen et al. Organogenesis
- Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]
- (2009) D Gareth R Evans GENETICS IN MEDICINE
- Neurofibromatosis type 2 (NF2): A clinical and molecular review
- (2009) D Gareth R Evans Orphanet Journal of Rare Diseases
- Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression
- (2008) Yulun Huang et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started